- Home
- VCEL vs TRLV Comparison
VCEL vs TRLV Comparison
Compare VCEL & TRLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCEL | TRLV |
|---|---|---|
| Founded | 1989 | 1940 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VCEL | TRLV |
|---|---|---|
| Price | $57.38 | $10.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $65.43 | $18.32 |
| AVG Volume (30 Days) | 839.6K | ★ 1.3M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | 26.58 |
| EPS | ★ 0.19 | N/A |
| Revenue | $276,259,000.00 | ★ $1,181,180,000.00 |
| Revenue This Year | $24.98 | N/A |
| Revenue Next Year | $15.37 | N/A |
| P/E Ratio | $299.79 | ★ N/A |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $7.82 |
| 52 Week High | $59.75 | $12.93 |
Technical Indicators
Market Signals| Indicator | VCEL | TRLV |
|---|---|---|
| Relative Strength Index (RSI) | 74.24 | 48.74 |
| Support Level | $31.94 | $10.71 |
| Resistance Level | N/A | $11.86 |
| Average True Range (ATR) | 2.65 | 0.66 |
| MACD | 1.52 | 0.02 |
| Stochastic Oscillator | 88.85 | 44.65 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About TRLV Trulieve Cannabis Corp. Subordinate Voting Shares
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.